Pacific Biosciences Of California | PACB - Des Atouts





Des Atouts Changement Date
Agilent USD 13.07B 252M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Danaher USD 83.54B 80M 2026-03
General Electric Aerospace USD 128.45B 1.72B 2026-03
Illumina USD 6.56B 85M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Quidel USD 5.63B 140.6M 2026-03
Revvity USD 12B 171.82M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Waters USD 24.53B 19.45B 2026-03